多学科头颈癌治疗的演变
本综述回顾了头颈鳞状细胞癌(HNSCC)两个世纪以来的治疗演变,聚焦多学科治疗范式。手术最初是唯一手段,放疗、化疗和免疫治疗先后拓展了治疗格局,但现代治疗仍根植于多学科个体化方法。黏膜HNSCC根治性治疗中免疫治疗的作用仍在形成中,需更多III期试验明确最佳治疗。
要点
- 手术最初是HNSCC唯一治疗手段,放疗、化疗和免疫治疗逐步拓展治疗选择。
- 现代HNSCC治疗仍以多学科、个体化方法为核心,常需多种治疗模式联合。
- 铂类化疗仍是HNSCC全身治疗支柱,免疫与靶向治疗应用加速增长。
核心结论
- 手术与放疗在降低并发症和治疗后遗症方面持续取得进展。
- 铂类化疗仍是HNSCC全身治疗的主要手段,免疫治疗和靶向治疗的应用加速增长。
- 全面的头颈癌诊疗依赖多学科管理,通常需要多种治疗模式并对疗法和治疗目标进行个体化。
- 需要额外的III期试验来进一步明确HNSCC的最佳治疗。
研究设计与样本
- 历史综述,综合历史与当前临床试验、书籍、科学报告、公开文件及其他相关书面材料。
主要发现
- 手术最初是唯一可用的治疗,放疗、化疗和免疫治疗拓展了HNSCC的治疗格局。
- 免疫治疗改善了复发/转移性黏膜HNSCC和皮肤恶性肿瘤的结局,但其在黏膜HNSCC根治性治疗中的作用仍在形成中。
- 不同治疗的最佳时机、应用和范围,包括新辅助治疗的作用,仍在研究中。
关键数值与推荐
- 本综述重点介绍了建立诊疗标准的临床先驱以及推动标准进展的里程碑试验。
临床怎么用
- 全面的头颈癌诊疗依赖多学科管理,通常需要多种治疗模式并个体化疗法与治疗目标。
局限性
- 不同治疗的最佳时机、应用和范围,包括新辅助治疗的作用,仍在研究中。
- 免疫治疗在黏膜HNSCC根治性治疗中的作用仍在形成中。
- 需要额外的III期试验来进一步明确HNSCC的最佳治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The management of head and neck squamous cell carcinoma (HNSCC) has substantially changed over the past two centuries. This review explores the historical progression of HNSCC management focusing on the multidisciplinary treatment paradigm. DATA SOURCES: This review synthesizes data from historical and current clinical trials, books, scientific reports, public documents, and other written material relevant to HNSCC management. REVIEW METHODS: Historical review. RESULTS: Although surgery was initially the only treatment available, radiation, chemotherapy, and immunotherapy have expanded the treatment landscape for HNSCC. Despite continuous evolution, modern treatment of HNSCC remains rooted in a multidisciplinary, personalized approach. This review highlights the clinical pioneers who established the standards of care and the landmark trials that progressed it. The optimal timing, application, and extent of different treatments, including the role of neoadjuvant therapy, remain under study. Immunotherapy has improved outcomes for recurrent/metastatic mucosal HNSCC and cutaneous malignancies, although its role in the curative management of mucosal HNSCC is still materializing. CONCLUSIONS: Surgery and radiotherapy have made continued gains in reducing morbidity and treatment sequala. Platinum-based chemotherapy remains the mainstay of systemic therapy for HNSCC, but there has been accelerated growth in the application of immunotherapy and targeted therapy. Comprehensive head and neck cancer care depends on multidisciplinary management, usually requiring multiple treatment modalities while individualizing both the therapies and treatment goals. Additional phase III trials are needed to further define the optimal treatments for HNSCC.
引用
- Contrera KJ, Reddy PD, Helou V, et al. The Evolution of Multidisciplinary Head and Neck Cancer Treatment. Laryngoscope. 2025. PMID: 39960134. doi:10.1002/lary.32064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。